We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A liquid biopsy exosomal microRNA (miRNA) panel can accurately predict cancer recurrence following surgery for pancreatic ductal adenocarcinoma, according to a study presented at Digestive Disease Week (DDW) 2021.